Page last updated: 2024-09-02

cgp 39551 and organophosphonates

cgp 39551 has been researched along with organophosphonates in 1 studies

Compound Research Comparison

Studies (cgp 39551)	Trials (cgp 39551)	Recent Studies (post-2010) (cgp 39551)	Studies (organophosphonates)	Trials (organophosphonates)	Recent Studies (post-2010) (organophosphonates)
75	0	4	9,968	880	3,596

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cebere, A; Cebers, G; Kosowski, AR; Liljequist, S; Swanhagen, AC	1

Other Studies

1 other study(ies) available for cgp 39551 and organophosphonates

Article	Year
Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551. Psychopharmacology, 2004, Volume: 175, Issue:1 Topics: 2-Amino-5-phosphonovalerate; Animals; Cell Survival; Cells, Cultured; Cerebellum; Dopamine; Male; Microdialysis; Motor Activity; Nicotine; Nucleus Accumbens; Organophosphonates; Quinoxalines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Time Factors	2004

Article

Year

Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.

Psychopharmacology, 2004, Volume: 175, Issue:1

Topics: 2-Amino-5-phosphonovalerate; Animals; Cell Survival; Cells, Cultured; Cerebellum; Dopamine; Male; Microdialysis; Motor Activity; Nicotine; Nucleus Accumbens; Organophosphonates; Quinoxalines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Time Factors

2004